Evaluation of a Bronchoalveolar Lavage Procedure With a Flexible Disposable Bronchoscope, Ambu aScope 3 Large in Patients in an Intensive Care Unit Setting
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atelectasis
- Sponsor
- Ambu A/S
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Improvement in Oxygenation (PaO2/FiO2 Ratio) After a BAL Treatment
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
An Investigation to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung.
Detailed Description
The purpose of this investigation it to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung. The hypothesis is that aScope 3 Large is able to manage the secretion and thereby facilitating the resolution of secretion in the lung.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients ≥18 years
- •Clinical indication and eligible for a BAL procedure, as judged by the investigator
- •Patients being admitted in the ICU at the investigational centre
- •Provision of signed IC by subject, or subject's legal representative e.g. next of kin
Exclusion Criteria
- •Patients where BAL treatment cannot be clinically justified, judged by the investigator
- •ETT \>7 mm and ≤8.5 mm in diameter
- •Participating in other interventional clinical investigations or have previously participated in this investigation
Outcomes
Primary Outcomes
Improvement in Oxygenation (PaO2/FiO2 Ratio) After a BAL Treatment
Time Frame: 4 hours after procedure
Resolution of atelectasis measured by improvement in oxygenation after a bronchoscopic procedure (bronchoalveolar lavage treatment). PaO2/FiO2 ratio will be compared between baseline and 4 hourst post the BAL procedure.